Lipid levels in high density lipoprotein subfractions in smokers with peripheral vascular disease

Area of Science:

• Cardiovascular Medicine
• Lipid Metabolism
• Smoking-Related Diseases

Background:

• Peripheral vascular disease (PVD) is a common complication of smoking.
• Lipid profiles are known to be affected by smoking and cardiovascular health.
• Understanding lipid changes in PVD patients who smoke is crucial for risk assessment.

Purpose of the Study:

• To investigate the differences in lipid profiles between smokers with PVD and controls.
• To assess the impact of smoking on specific lipid components in the context of PVD.

Main Methods:

• Comparison of serum lipid levels (HDL, VLDL, LDL, triglycerides, phospholipids) between a cohort of smokers with PVD and a control group.
• Calculation of the ratio of HDL cholesterol to the sum of (VLDL + LDL) cholesterol.

Main Results:

• No significant difference in high-density lipoprotein (HDL) cholesterol levels was observed between smokers with PVD and controls.
• A reduced ratio of HDL cholesterol to the sum of very low-density lipoprotein (VLDL) and low-density lipoprotein (LDL) cholesterol was found in PVD patients.
• Significantly higher serum triglyceride levels were present in patients with PVD.
• Slightly significant differences were noted in serum cholesterol and serum phospholipid concentrations in smoking patients with PVD.

Conclusions:

• While HDL cholesterol levels may not differ, smoking-associated PVD significantly alters other lipid parameters.
• The reduced HDL/ (VLDL + LDL) ratio and elevated triglycerides indicate a dyslipidemic profile in these patients.
• These lipid alterations may contribute to the progression or severity of PVD in smokers.